No association between SCN9A and monogenic human epilepsy disorders
No Thumbnail Available
Authors
Fasham, James
Crosby, Andrew H.
Baple, Emma L.
Journal
PLoS Genetics
Type
Journal Article
Publisher
Public Library of Science
Rights
© 2020 Fasham et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which
permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
CC0 1.0 Universal
CC0 1.0 Universal
Many studies have demonstrated the clinical utility and importance of epilepsy gene panel testing to confirm the specific aetiology of disease, enable appropriate therapeutic interventions, and inform accurate family counselling. Previously, SCN9A gene variants, in particular a c.1921A>T p.(Asn641Tyr) substitution, have been identified as a likely autosomal dominant cause of febrile seizures/febrile seizures plus and other monogenic seizure phenotypes indistinguishable from those associated with SCN1A, leading to inclusion of SCN9A on epilepsy gene testing panels. Here we present serendipitous findings of genetic studies that identify the SCN9A c.1921A>T p.(Asn641Tyr) variant at high frequency in the Amish community in the absence of such seizure phenotypes. Together with findings in UK Biobank these data refute an association of SCN9A with epilepsy, which has important clinical diagnostic implications.
Citation
Fasham J et al. No association between SCN9A and monogenic human epilepsy disorders. PLoS Genet. 2020 Nov 20;16(11):e1009161.
Publisher URL
Note
This article is available to RD&E staff via NHS OpenAthens. Click on the Publisher URL, and log in with NHS OpenAthens if prompted.